Edith WK Chow

Endocrinologist by day🩺| mom, wife, toddler negotiator by night👶🏻📝 researcher and clinical lecturer at @CUHKMedicine. opinions my own.

[Dr Ronald Ma @DrRonaldMa1]

This analysis by Xinge Zhang in individuals with T2 #diabetes followed up from diagnosis to incident cancers noted higher risks of #cancers related to hyperglycaemia, especially those with early exposure to hyperglycaemia, cf to later exposure
@Andrea_OY_Luk
@CUHKMedicine

[Edith WK Chow @EWKChow]

Our first of two studies highlighting the burden of hypertension in young people with type 2 diabetes. 🩸📊

[Diabetes Care, an ADA research journal 🌟 @DiabetesCareADA]

Hypertension before age 45 increases the risk of cardiovascular disease, kidney disease and death in T2D. Awareness of raised BP among young individuals is essential.

Read here ➡️ https://t.co/3Q8Herg89c

@AmDiabetesAssn @ADA_DiabetesPro @ADA_Pubs

[CUHK Medicine @CUHKMedicine]

On 5 February 2026, The Chinese University of Hong Kong (CUHK) Clinical Trial Centre (CTC) successfully held its inaugural symposium at the CUHK Medical Centre Auditorium. Under the theme “Create, Transform, Cure”, the event brought together over 200 distinguished guests from academia, government, industry, and innovation sectors to explore Hong Kong’s role as a global hub for clinical innovation.

[Edith WK Chow @EWKChow]

@gechang_yu @DrRonaldMa1 @DiabetologiaJnl @CUHKMedicine Congratulations @gechang_yu and @DrRonaldMa1 !

[CUHK Medicine @CUHKMedicine]

To combat the silent epidemic of young-onset diabetes (YOD), we are launching a four-year DNA testing programme, namely “Jockey Club Precision Prevention Programme” which aims to screen 9,000 adults aged 18 to 44 to identify those with a genetic predisposition to YOD and at high risk of developing diabetes in the next decade, for prevention or delay of onset of the disease.🧬

Join now: https://t.co/NzWKQng5MM
Details: https://t.co/49bi2agsYD

[CUHK Medicine @CUHKMedicine]

@CUHKMedicine learned from the @UniofOxford’s UK Prospective Diabetes Study Outcomes Model and developed the first Chinese Diabetes Outcome Model, using big data of over 21,000 type 2 diabetes patients gathered continuously from the Hong Kong Diabetes Register. The model has been validated to predict the lifetime risks of 10 major complications in individual type 2 diabetes patients based on routine measurements.

@DiabetesCareADA
@Chan68873575 (Prof. Juliana Chan)

[CUHK Medicine @CUHKMedicine]

@CUHKMedicine’s 20-year follow-up on over 500 mother-child pairs has provided important new insights into the long-term impact of maternal hyperglycaemia on mothers and offspring, increasing risks in overweight and elevated blood sugar levels. The research team has also identified DNA methylation markers that could explain these long-term effects.

@DiabetologiaJnl
@Diabetes_ADA

[Edith WK Chow @EWKChow]

@DrRonaldMa1 @dengyuzhi0104 Congratulations again @dengyuzhi0104 and @DrRonaldMa1 !!

[Edith WK Chow @EWKChow]

Great commentary by Dr. Flack and colleagues .
Key questions on PA screening💭
1️⃣will more PA screening improve followup care
2️⃣how to stratify patient for lateralisation considering limited AVS availability
3️⃣how to implement expanded PA screening without straining healthcare

[Hypertension @HyperAHA]

COMMENTARY: Expanding the Search for Primary Aldosteronism in Clinical Settings

https://t.co/4vPuQSJEPh

[Hypertension @HyperAHA]

RESEARCH ARTICLE: Cosyntropin-Stimulated Aldosterone Reserve of the Nondominant Adrenal Predicts Surgical Outcomes in Primary Aldosteronism @adina_turcu

https://t.co/Y47MEkFcr0

[Edith WK Chow @EWKChow]

10 presentations from @CUHKMedicine at #EASD2025‼️
fortunate to be surrounded by
a talented group of people with diverse backgrounds unified by the goal to improve the care of people with DM.
Thank you @DrRonaldMa1 for your mentorship and guidance.
@dengyuzhi0104
@gechang_yu

[Edith WK Chow @EWKChow]

Great talk by Dr. Martin Wabitsch on SURPASS-PEDS! Where do we stand on treating youth T2DM?

Despite TZD results,
There are no quick fixes❌.

✅Success needs MDT care with psychological support, lifestyle counseling, and family involvement🏡🧑‍🧑‍🧒 #EASD2025

[Edith WK Chow @EWKChow]

Such an inspiring and heartfelt talk by Dr. Vanita Aroda @ArodaMd , reminding us the core foundation of clinical trials - it’s all about the patient💖
#EASD2025

[Edith WK Chow @EWKChow]

Humbled by the opportunity to share our work today at #EASD2025! Excited for more updates from @CUHKMedicine’s Division of Diabetes & Endocrinology in the coming days!

[CUHK Medicine @CUHKMedicine]

Supported by the Hong Kong government’s Office for Attracting Strategic Enterprises (OASES), the Phase 1 Clinical Trial Centre under the CUHK Clinical Trial Centre has successfully initiated a First-in-Human clinical study with a world-leading pharmaceutical company in a short period, quickly completing approvals and recruiting the world’s first batch of Chinese patients.

👩🏻‍⚕️👨🏻‍⚕️Full Article: https://t.co/6nPyNFiRie

[ERM @Owner_X429]

Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: https://t.co/oVJpDstmg3

[Edith WK Chow @EWKChow]

Food for thought as we advocate for broader screening of PA to all people with hypertension.
What’s next and how can we enhance the diagnostic pathway?

[Euro J Endocrinology @EJEndo]

A global real-world study assessing total time to adrenalectomy in primary aldosteronism by Charmaine Ter et al

EJE Volume 193, Issue 1, July 2025
Open access article 👉 https://t.co/rwX0dTL3OY

#endocrinology #adrenalectomy #aldosteronism

[Edith WK Chow @EWKChow]

Congratulations @ElaineC48486251 and team!

[CUHK Medicine @CUHKMedicine]

.@CUHKMedicine finds that a moderate intake of FODMAPs boosts metformin’s efficacy in preventing prediabetes from progression to type 2 #diabetes. ▶️https://t.co/b9q2FlXxTq

📖@NatMetabolism: https://t.co/OVufFo9l3L

[Edith WK Chow @EWKChow]

Pre-specified secondary analysis from FLOW:

No difference in renal benefits of semaglutide with or without baseline MRA use.

Those on MRA saw greater absolute risk reduction for kidney outcomes—NNT 9 vs 23

Moving forward : Sequential VS early combination therapies for DKD?

[Edith WK Chow @EWKChow]

https://t.co/QcykLaNkNl

[Edith WK Chow @EWKChow]

Great piece from @NEJM

For early learners, substituting clinical reasoning with AI risks never- or mis-skilling.

Without critical thinking, reliance on AI drives biases that may ultimately outweigh the benefits of this technology.

Importance for educators to guide use of AI